Eli Lilly and (LLY) Revenue — Quarter Ended Sep 30, 2024
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The year-over-year growth was robust, while the sequential gain was more measured.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The year-over-year growth was robust, while the sequential gain was more measured.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.4B
Revenue reported for this quarter.
Quarter-over-quarter
+1.2%
Change from the immediately preceding quarter.
Year-over-year
+20.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$40.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $9.4B | +28.1% |
| Mar 31, 2024 | $8.8B | +26.0% |
| Jun 30, 2024 | $11.3B | +36.0% |
| Sep 30, 2024 | $11.4B | +20.4% |
Revenue performance
The company reported higher revenue for the quarter, reflecting a significant rise from the prior year and a slight uptick from the previous quarter.
Quarterly comparison
Compared to the same period a year ago, revenue posted a notable increase. Sequentially, revenue edged higher relative to the prior quarter.
What to watch
The quarter's revenue growth, while positive, slowed sequentially compared to the prior quarter's pace.